...
首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Comparative evaluation of simultaneous administration of mifepristone and misoprostol; and misoprostol alone for induction of second trimester abortion
【24h】

Comparative evaluation of simultaneous administration of mifepristone and misoprostol; and misoprostol alone for induction of second trimester abortion

机译:米非司酮和米索前列醇同时给药的比较评价;和米索前列醇单独诱导中期妊娠流产

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The present study was conducted with the aim to assess the safety and efficacy of misoprostol alone and misoprostol with simultaneous mifepristone for second trimester termination of pregnancy. Methods: The study was conducted on 160 cases, divided in two groups of 80 cases each. In the study group 200?mg mifepristone and 200 μgm misoprostol given together on admission followed by miso every 3 hrs upto a maximum of 8 doses or until the abortion occurs, whichever occurs early. In the control group only miso was given in the same dose regime. If abortion did not occur within this duration it was considered failure of method. The results were analysed. Results: The success rate in first regimen was 98%. Mean induction abortion interval was significantly shorter in the study group, 8.62±1.96?h as compared to 14.5±3.01?h in the control group. The mean dose of the misoprostol required was significantly less in study group. The side effects like nausea, vomiting, fever, abdominal cramps, diarrhoea were observed more in control group (30%) in comparison to study group (12.1%). Conclusions: Mifepristone with simultaneous misoprostol is better than misoprostol alone and there is no need to wait for 24 hr after mifepristone for administration of misoprostol.
机译:背景:本研究旨在评估米索前列醇和米索前列醇同时米非司酮用于终止妊娠中期的安全性和有效性。方法:研究对象为160例,分为两组,每组80例。在研究组中,入院时同时服用200 mg米非司酮和200μg米索前列醇,然后每3小时进行味o,最多8剂或直至流产发生,以较早发生者为准。在对照组中,在相同的剂量方案中只服用味o。如果在这段时间内没有发生流产,则认为方法失败。分析结果。结果:第一方案的成功率为98%。研究组的平均诱导流产间隔显着缩短,为8.62±1.96?h,而对照组为14.5±3.01?h。研究组所需米索前列醇的平均剂量显着降低。与研究组(12.1%)相比,对照组(30%)观察到更多的恶心,呕吐,发烧,腹部绞痛,腹泻等副作用。结论:米非司酮联合米索前列醇比单独使用米索前列醇更好,并且无需在米非司酮注射后24小时再服用米索前列醇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号